Wells Fargo Maintains Overweight on United Therapeutics, Raises Price Target to $703

Benzinga · 1d ago
Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $700 to $703.